Menu

Blog

Archive for the ‘biotech/medical’ category: Page 1957

Apr 13, 2018

Moving Closer to a Vaccine for Atherosclerosis

Posted by in categories: biotech/medical, life extension

Scientists could be one step closer to a solution to atherosclerosis by preventing the buildup of plaques that clog the arteries and lead to strokes and heart attacks.

What is atherosclerosis?

Atherosclerosis is the accumulation of cholesterol-containing plaques in the walls of arteries; this causes them to narrow, leading to reduced blood flow, higher blood pressure, and an increased risk of a heart attack or stroke. Atherosclerosis is the number one cause of death globally, and, by far, the highest risk factor for this disease is aging, although there are lifestyle factors, such as poor diet, smoking, obesity, and being sedentary.

Continue reading “Moving Closer to a Vaccine for Atherosclerosis” »

Apr 13, 2018

Memory Successfully Boosted In Humans

Posted by in categories: biotech/medical, cyborgs, mathematics, neuroscience

Scientists from Wake Forest Baptist Medical Center partnered with researchers from the University of Southern California to develop an innovative procedure to give hope to people struggling with remembering important information. A new implant uses a person’s own memory patterns in order to boost the brain’s natural ability to encode those memories and recall them quickly. There has been a reported 35 to 37 % increase in short-term memory performance.

“This is the first time scientists have been able to identify a patient’s own brain cell code or pattern for memory and, in essence, ‘write in’ that code to make existing memory work better, an important first step in potentially restoring memory loss,” said the study’s lead author Robert Hampson, Ph.D., professor of physiology/pharmacology and neurology at Wake Forest Baptist.

Epilepsy patients from Wake Forest Baptist were surgically implanted with electrodes in the various parts of their brains. The electronic prosthetic system is based on a multi-input-multi-output (or MIMO) mathematical model to influence the patterns of neurons firing within the hippocampus.

Continue reading “Memory Successfully Boosted In Humans” »

Apr 13, 2018

‘We’re Out of Options’: Doctors Battle Drug-Resistant Typhoid Outbreak

Posted by in category: biotech/medical

An aggressive typhoid strain, resistant to five types of antibiotics, is expected to replace other endemic strains worldwide. It could evolve to become untreatable.

Read more

Apr 13, 2018

Robot Cities: Three Urban Prototypes for Future Living

Posted by in categories: biotech/medical, economics, finance, governance, internet, robotics/AI

Before I started working on real-world robots, I wrote about their fictional and historical ancestors. This isn’t so far removed from what I do now. In factories, labs, and of course science fiction, imaginary robots keep fueling our imagination about artificial humans and autonomous machines.

Real-world robots remain surprisingly dysfunctional, although they are steadily infiltrating urban areas across the globe. This fourth industrial revolution driven by robots is shaping urban spaces and urban life in response to opportunities and challenges in economic, social, political, and healthcare domains. Our cities are becoming too big for humans to manage.

Continue reading “Robot Cities: Three Urban Prototypes for Future Living” »

Apr 13, 2018

Bioquark Inc. — Illuminations Media — Ira Pastor

Posted by in categories: aging, bioengineering, biotech/medical, business, health, innovation, life extension, neuroscience, science, transhumanism

Apr 13, 2018

Bioquark Inc. — Core Brain Podcast — Ira Pastor

Posted by in categories: aging, bioengineering, biological, biotech/medical, disruptive technology, DNA, futurism, genetics, neuroscience, science

http://www.corebrainjournal.com/2018/04/211-regenerative-bio…cs-pastor/

Apr 13, 2018

Non-profit’s $300 hepatitis C cure as effective as $84,000 alternative

Posted by in category: biotech/medical

Exclusive: 71 million people stand to benefit from reduced price treatment for virus which can lead to liver cirrhosis, cancer and death.

Thu 12 Apr 2018 01.00 EDT Last modified on Thu 12 Apr 2018 19.55 EDT.

Continue reading “Non-profit’s $300 hepatitis C cure as effective as $84,000 alternative” »

Apr 13, 2018

Looking to Listen: Audio-Visual Speech Separation

Posted by in categories: biotech/medical, information science, robotics/AI

People are remarkably good at focusing their attention on a particular person in a noisy environment, mentally “muting” all other voices and sounds. Known as the cocktail party effect, this capability comes natural to us humans. However, automatic speech separation — separating an audio signal into its individual speech sources — while a well-studied problem, remains a significant challenge for computers.

In “Looking to Listen at the Cocktail Party”, we present a deep learning audio-visual model for isolating a single speech signal from a mixture of sounds such as other voices and background noise. In this work, we are able to computationally produce videos in which speech of specific people is enhanced while all other sounds are suppressed. Our method works on ordinary videos with a single audio track, and all that is required from the user is to select the face of the person in the video they want to hear, or to have such a person be selected algorithmically based on context. We believe this capability can have a wide range of applications, from speech enhancement and recognition in videos, through video conferencing, to improved hearing aids, especially in situations where there are multiple people speaking.

Continue reading “Looking to Listen: Audio-Visual Speech Separation” »

Apr 12, 2018

Brain adapts after rare dementia attacks language center

Posted by in categories: biotech/medical, neuroscience

People with a rare kind of dementia that initially attacks the language center of the brain end up recruiting other areas of the brain to decipher sentences, according to a new study.

The study is one of the first to show that people with a neurodegenerative disease can call upon intact areas of the brain for help. People who have had strokes or traumatic brain injuries sometimes use additional regions of the brain to accomplish tasks that were handled by the now-injured part.

“We were able to identify regions of the brain that allowed the patients to compensate for the dying of neurons in the brain,” says first author Aneta Kielar, an assistant professor of speech, language, and hearing sciences and of cognitive science at the University of Arizona.

Read more

Apr 12, 2018

Scientists Edit Thousands of Genes at Once With Upgraded CRISPR

Posted by in categories: bioengineering, biotech/medical, genetics

When the gene-editing technology CRISPR first made a splash back in 2012, it foretold a future in which curing diseases might simply involve snipping out problematic bits of genetic code. Of course, innovation is rarely so straightforward. As incredible as CRISPR is, it also has some pretty sizable flaws to overcome before it can live up to its hype as a veritable cure-all for human disease.

A new study published this week in the journal Nature Genetics tackles one CRISPR complication. CRISPR gene-editing systems can easily cut many pieces of DNA at once, but actually editing all those genes is a lot more time-consuming. Now, scientists at UCLA have come up with a way to edit multiple genes at once.

When scientists use CRISPR for genetic engineering, they are really using a system made up of several parts. CRISPR is a tool taken from bacterial immune systems. When a virus invades, the bacterial immune system sends an enzyme like Cas9 to the virus and chops it up. The bacteria then adds short bits of virus DNA to its own code, so it can recognize that virus quickly in the future. If the virus shows up again, a guide RNA will lead the Cas9 enzyme to the matching place in the virus code, where it again chops it up. In CRISPR, when that cutting is done, scientists can also insert a new bit of code or delete code, to, for example, fix disease-causing genetic mutations in the code before patching it up. But delivering that new code and making the patch is where it can get especially tricky.

Continue reading “Scientists Edit Thousands of Genes at Once With Upgraded CRISPR” »